Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Tirzepatide; Drug: Insulin Glargine Sponsor: Nanjing First Hospital, Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2022 Category: Research Source Type: clinical trials
Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
September 21, 2022 -- In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 21, 2022 Category: Pharmaceuticals Source Type: clinical trials
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
Conditions: Diabetes Mellitus, Type 2; Obesity Interventions: Drug: Semaglutide; Drug: Insuline glargine (reduced); Drug: Insuline glargine (titrated) Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2022 Category: Research Source Type: clinical trials
